Filter
889
Filtered Results: 889
Text search:
The
Pharmacy
and
Drugs
Distribution
Featured
Recommendations
76
New Publications
327
Language
Document type
No document type
560
Studies & Reports
129
Guidelines
124
Manuals
35
Strategic & Response Plan
19
Training Material
10
Situation Updates
6
Fact sheets
5
Online Courses
1
Countries / Regions
Kenya
60
Ethiopia
46
India
38
Sierra Leone
34
South Africa
34
Nigeria
33
Uganda
30
Liberia
27
Nepal
27
Rwanda
26
Malawi
25
Ghana
23
Tanzania
23
Zambia
20
Lesotho
17
Zimbabwe
16
Bangladesh
16
Namibia
16
Botswana
15
Global
11
Ukraine
10
Latin America and the Carribbean
9
Burkina Faso
8
Cameroon
8
Philippines
8
Indonesia
8
Myanmar / Burma
8
Western and Central Europe
7
Cambodia
6
Senegal
5
Congo, Democratic Republic of
5
Haiti
5
Benin
5
South–East Asia Region
5
Tajikistan
5
Guinea
4
South Sudan
4
Mozambique
4
Eswatini/ Swaziland
4
Russia
4
Pakistan
3
Thailand
3
Eastern Europe and Central Asia
3
Paraguay
3
Eastern Europe
3
Mali
2
Afghanistan
2
Lebanon
2
Syria
2
Central African Republic
2
Serbia
2
Sri Lanka
2
East and Southern Africa
2
Middle East and North Africa
2
Asia
2
Africa
2
Bhutan
2
Albania
2
Mongolia
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
Vietnam
2
Côte d’Ivoire / Ivory Coast
1
Jordan
1
Germany
1
Egypt
1
Chad
1
China
1
Sudan
1
Brazil
1
North Macedonia
1
Libya
1
Angola
1
West and Central Africa
1
Western Pacific Region
1
Venezuela
1
Armenia
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Moldova
1
Uzbekistan
1
Gabon
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
539
Clinical Guidelines
45
Public Health
30
Women & Child Health
16
Capacity Building
14
Key Resources
13
Pharmacy & Technologies
13
Toolboxes
Pharmacy
97
AMR
74
HIV
67
TB
40
Mental Health
23
COVID-19
19
Caregiver
15
NCDs
11
Ebola
10
Conflict
9
Rapid Response
8
NTDs
8
Global Health Education
5
Disability
4
Refugee
4
Planetary Health
4
Natural Hazards
3
Specific Hazards
3
Zika
2
Health Financing Toolbox
2
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – ... this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pandemic laid this inequity bare, it also saw the pharmaceutical industry develop and bring new vaccines and treat- ments to market at unprecedented speed. As the world emerges from the worst
of this crisis, pharmaceutical companies are now at an important juncture, where lessons learned from the pandemic can prove pivotal in finding solutions to bridge long-standing gaps in access to medicine in LMICs.
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. ... study assessed medicines availability and affordability, geographical accessibility, quality and rational use among other issues. The survey was conducted in six regions. In each region, 6 public health care facilities, 12 private pharmacies and 1 warehouse were surveyed.
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and...
Afr J Tradit Complement Altern Med. (2016) 13(4):123-131
Out of 400 questionnaires distributed to the participants, 389 were returned with data acceptable for analysis. Ages of the participants...
Out of 400 questionnaires distributed to the participants, 389 were returned with data acceptable for analysis. Ages of the participants...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to...
Bull World Health Organ 2017;95:594–598
5th edition.
The "Global NCD action plan" provides a road map and a menu of policy options for countries to take in order to attain the 9 voluntary global targe...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance deve...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity ... mortality. In addition, there is compelling evidence that antimicrobial resistance is driven by the volume of antimicrobial agents used. High rates of antimicrobial resistance to common treatments are currently reported all over the world, both in health care settings and in the community. For over two decades, the Region of the Americas has been a pioneer in confronting antimicrobial resistance from a public health perspective. However, those efforts need to be stepped up if we are to have an impact on antimicrobial resistance and want to quantify said impact.
This report describes the work done by WHO from January 2015 up to the end of December 2016 to address the long-term issues of survivor care, healt...
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
